Stay updated on Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The NIH announcement about terminology changes during the agency transition was removed from the page. The study record still displays a 403 error.
    Difference
    1%
    Check dated 2026-11-07T14:54:17.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T15:36:55.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide banner announces that NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T18:38:54.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer’s site revision label was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T18:23:01.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page’s footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T19:16:12.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error, replacing the previously visible study record content with an access-denied screen. This indicates the main study details are currently inaccessible on the page.
    Difference
    21%
    Check dated 2026-09-19T22:03:29.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.